Nanoviricides, Inc. (NNVC) — 10-Q Filings

10-Q Filings (6)

• NanoViricides Narrows Q1 Loss Amid Cash Crunch, Eyes NV-387 Milestones — Nov 14, 2025 Risk: high
  NanoViricides, Inc. (NNVC) reported a net loss of $1,785,058 for the three months ended September 30, 2025, a significant improvement from the $3,126,811 net lo
• NanoViricides, Inc. Files Q3 2025 10-Q — May 15, 2025 Risk: medium
  NanoViricides, Inc. filed its 10-Q for the period ending March 31, 2025. The company, incorporated in Nevada, operates in the pharmaceutical preparations sector
• NanoViricides Reports Q2 Results — Feb 14, 2025 Risk: high
  NanoViricides, Inc. filed its 10-Q for the period ending December 31, 2024. The company reported total assets of $13,144,055 and total liabilities of $1,564,161
• NanoViricides Reports Q3 2024 Results — Nov 14, 2024 Risk: medium
  NanoViricides, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported total assets of $14.06 million and total liabilities of $1.31
• Nanoricides, Inc. Files 10-Q for Period Ending March 31, 2024 — May 15, 2024 Risk: low
  NANOVIRICIDES, INC. (NNVC) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Nanoricides, Inc. filed a 10-Q report for the period ending March 31, 2
• Nanorviricides, Inc. Files 10-Q for Period Ending December 31, 2023 — Feb 14, 2024 Risk: medium
  NANOVIRICIDES, INC. (NNVC) filed a Quarterly Report (10-Q) with the SEC on February 14, 2024. Nanorviricides, Inc. filed a 10-Q for the period ending December 3

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX